The Hymed Group Corporation

Home Up Feedback Search

Chondroprotec
CellerateRX hyCURE hyCURE SMART GEL HYCOAT Chondroprotec PiercingCare

 

                            chondro.gif (6822 bytes)

  CHONDROPROTEC®

    Polysulfated glycosaminoglycan.                    

    Patented Topical Wound Management Dressing

    Chondroprotective agents are natural substances such as glycosaminoglycans that support or enhance the connective tissue matrix and, as such, are found in the chemical composition of connective tissue and soft tissue in humans and animals. These compounds have become beneficial in the management of chronic and acute wounds. Polysulfated glycosaminoglycans rehydrate dry wounds, maintain a moist healing environment, 1-2-3 and protect from tissue trauma2.

Description:

CHONDROPROTEC® is a sterile 10 mL solution containing 1000 mg of polysulfated glycosaminoglycan. Sodium hydroxide and/or hydrochloric acid is added when necessary to adjust pH to 6.5 - 6.7.

Indications:

CHONDROPROTEC® is indicated for use in the management of :
bulletPressure Ulcers (Stages I-IV)
bulletPartial and Full Thickness Wounds
bulletVenous Stasis Ulcers
bulletFirst and Second Degree Burns
bulletSecreting and Bleeding Dermal Lesions
bulletTrauma Injuries
bulletSurgical Incisions
bulletDonor Sites

Characteristics:

bulletcreates an optimal moist wound healing environment
bulletprotects new granulation tissue
bulletpromotes natural autolysis by rehydrating and softening necrotic tissue and eschar thereby encouraging autolytic debridement
bulletconforms to any wound site
bulleteasy to apply and redress

Precautions and Contraindications:

bulletNo known side effects, not intended for use as a long-term or permanent dressing.
bulletCHONDROPROTEC® is to be dispensed by prescription only.

Product Administration:

CHONDROPROTEC® is a sterile solution of polysulfated glycosaminoglycan and should be handled accordingly.

    To Apply:

  1. Irrigate wound with normal saline.
  2. Apply CHONDROPROTEC® liberally to wound surface.
  3. Cover with extra gauze or ABD pad (1st phase) – 24 to 96 hours, heavy drainage. Cover with Telfa (2nd phase)-light or no drainage.
  4. Change dressing as needed, repeating application of CHONDROPROTEC®.

*Wounds that are contaminated and/or infected should be debrided prior to using CHONDROPROTEC®.

    To Remove:

  1. Irrigate wound site with normal saline or sterile water.

Storage:

Store at controlled room temperature (15o – 30o C). Protect from freezing.

How Supplied:

CHONDROPROTEC® is supplied in a sterile 10 mL vial containing 1000 mg of polysulfated glycosaminoglycan.

Product Ordering Information:

Reorder #611710 - 1000mg/10mL vial CHONDROPROTEC®

References:

  1. Lassus, A. Jeskahen, L., et al: Imdeen for the treatment of degenerated skin in females. Journal of Int=l Research. 19(2): 147-52.
  2. Cooper, ML, Hansbrough, JF. Use of a composite skin graft composed of fibroblasts and a collagen-GAG matrix to cover full-thickness wounds. Surgery. Feb. 1991; 109(2): 198-207.
  3. Breborowitz, A. , et al: Glycosaminoglycan chondroitin sulfate prevent loss of ultra filtration during peritoneal dialysis in rats. Nephron. 1994; 67(3): 346-50.

HEALTH DISTRIBUTOR INQUIRIES WELCOME!

PLEASE E-MAIL ANITA M. PETITO AT hymed@hymed.com (include your name, company, telephone number(s) and e-mail address) or call 610-865-9876 between 9 AM – 5 PM EST.

If you are a veterinarian interested in purchasing CHONDROPROTEC®, contact a customer service representative at Neogen Corporation by calling 1-800-525-2022 or contact your favorite distributor.

The information given herein is believed to be reliable. However, no guarantee is made or liability assumed. The Hymed Group Corporation does not know all of the uses to which its products may be utilized or the condition of use. Therefore, The Hymed Group Corporation makes no claims or warranty concerning the fitness or suitability of the product for a particular use or purpose other than those outlined.

 

[ Home ] [ Up ]

Send mail to Anita Petito with questions or comments about this web site.
Copyright © 1998, 1999, 2000, 2001, 2002, 2003, 2004 The Hymed Group, all rights reserved. Use of and access to the information contained on this site is subject to the terms of our Legal Notice.
Last modified: August 30, 2004